ARQT · Arcutis Biotherapeutics, Inc.
$28.26
+0.73 (+2.65%)
At close · Jul 21
Market Cap
$3.53B
Shares
125.08M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Capacity | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2021-05-06 | $100,000,000 | — | — | — | 10-Q , filed 2026-05-06 |
Key facts
CIK
1787306
CUSIP
03969K108
13F (30d)
20 filings
20 filers
Visit website
Investor relations